Bioresorbable vascular scaffolds in ST-elevation myocardial infarction – OCT-guided implantation and mid-term OCT resultsd
Phase 4
- Conditions
- I21Acute myocardial infarction
- Registration Number
- DRKS00009788
- Lead Sponsor
- niversitätsklinikum Bonn
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting stopped after recruiting started
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
All Patients with STEMI and with a anatomically suitable coronarstatus
-Written agreement of the Patient
Exclusion Criteria
-Intellectual reduction, No suitable coronarstatus (ostial leasion, bifurcation, calc rich leasions)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method device-oriented composite endpoint within 36 Month (target lesion failure [TLF]), defined as the combination of cardiac death, target vessel MI, or clinically driven target lesion revascularisation (TLR), either percutaneous or surgical. Deaths that could not be attributed to another cause were re-garded as cardiac deaths. OCT subgroup: neointima formation after 4-6 month
- Secondary Outcome Measures
Name Time Method -TIMI 0, I, II, III Fluss<br>-Angina Pectoris <br>-Successfull Stent-Implantationen<br>-Target vessel failure (cardiac death, target vessel MI, or clinically driven target vessel revascularisation (TVR), and scaffold thrombosis (ST))<br>-Kidneyinjury<br>-Rhythm-Events